No splash...but the sales are beginning to show...
Obviously, the benefit of being a small cap stock is that earnings are initially irrelevant. You aren't buying this stock for today... your buying it for the future and for the platform. The cash burn for this company is $400K a month or less. Obviously, the more machines in the field the less the burn because the high margin disposables are being used.
The four questions I have that I really want the answer to are the following:
1. Current metric for disposables used in Canadian machines... more or less than expected
2. FDA timeline, if known
3. Funding plan
4. New Markets, current expected backlog...
The key issue is the funding and if they get FDA approval, whether that will allow them to secure some debt financing. Have they spoken about partnering in the US or do they plan on marketing themselves - I would guess building a marketing platform for the US would be extremely expensive upfront?
I would expect that building the "Home market" in the US will be a lot cheaper and easier to approach than going to build that export market through distributors ...
Once the FDA approval received you'll see they'll switch their marketing priorities and in case we don't see a partnership or buy-out the marketing effort doesn't need to be massive and can still be build-up gradually.